NK

Nagabhai Karabhai Keshavala

Active Director Director DIN 10745125
DIN 10745125 First appointment Aug 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Nagabhai Karabhai Keshavala

Data last updated:

Nagabhai Karabhai Keshavala is a Director at Avkesh Life Science Private Limited (since 2024). The company operates in Paper.

DIN 10745125
Primary Designation Director
Industry Paper
First Appointment 16 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avkesh Life Science Private Limited U21001GJ2024PTC154451
Director16 Aug 20242024Active

Board colleagues of Nagabhai Karabhai Keshavala

Directorship timeline

Open interactive timeline →
Avkesh Life Science Private Limited
Premium access

Shareholding and investment profile for Nagabhai Karabhai Keshavala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nagabhai Karabhai Keshavala

Nagabhai Karabhai Keshavala currently holds 1 directorship: Avkesh Life Science Private Limited (Director, since 16 Aug 2024).

Nagabhai Karabhai Keshavala was first appointed on 16 Aug 2024 as Director at Avkesh Life Science Private Limited.

The current boards of Nagabhai Karabhai Keshavala's companies include Arbham Rayde Modhvadiya (Avkesh Life Science Private Limited), Tamuben Mahendrabhai Odedara (Avkesh Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available